These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6271381)

  • 1. Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancer.
    Lininger TR; Fleming TR; Eagan RT
    Cancer; 1981 Nov; 48(10):2147-53. PubMed ID: 6271381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.
    Evans WK; Feld R; Murray N; Pater J; Shelley W; Willan A; Osoba D; Levitt M; Coy P; Hodson I
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):10-6. PubMed ID: 3020692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating non-cross resistant chemotherapy for small cell lung cancer.
    Fukuoka M; Takada M; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Kudoh S; Tamai S
    Jpn J Clin Oncol; 1986 Sep; 16(3):261-70. PubMed ID: 3022035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada.
    Evans WK; Feld R; Murray N; Willan A; Coy P; Osoba D; Shepherd FA; Clark DA; Levitt M; MacDonald A
    Ann Intern Med; 1987 Oct; 107(4):451-8. PubMed ID: 2820289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive disease small cell carcinoma of the lung: trial of non-cross resistant chemotherapy and consolidation radiotherapy.
    Dillman RO; Taetle R; Seagren S; Royston I; Koziol J; Mendelsohn J
    Cancer; 1982 May; 49(10):2003-8. PubMed ID: 6280831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled clinical trial testing two potentially non-cross-resistant chemotherapeutic regimens in small-cell carcinoma of the lung.
    Broder LE; Selawry OS; Charyulu KN; Ng A; Bagwell S
    Chest; 1981 Mar; 79(3):327-35. PubMed ID: 6258871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study.
    Livingston RB; Schulman S; Mira JG; Harker G; Vogel S; Coltman CA; Rivkin SE; Budd GT; Grever MR; Crowley JP
    Cancer Treat Rep; 1986 Dec; 70(12):1395-401. PubMed ID: 3024826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
    Murray N; Livingston RB; Shepherd FA; James K; Zee B; Langleben A; Kraut M; Bearden J; Goodwin JW; Grafton C; Turrisi A; Walde D; Croft H; Osoba D; Ottaway J; Gandara D
    J Clin Oncol; 1999 Aug; 17(8):2300-8. PubMed ID: 10561291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
    Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.
    Roth BJ; Johnson DH; Einhorn LH; Schacter LP; Cherng NC; Cohen HJ; Crawford J; Randolph JA; Goodlow JL; Broun GO
    J Clin Oncol; 1992 Feb; 10(2):282-91. PubMed ID: 1310103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study.
    Wampler GL; Heim WJ; Ellison NM; Ahlgren JD; Fryer JG
    J Clin Oncol; 1991 Aug; 9(8):1438-45. PubMed ID: 1649265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.
    Feld R; Evans WK; Coy P; Hodson I; MacDonald AS; Osoba D; Payne D; Shelley W; Pater JL
    J Clin Oncol; 1987 Sep; 5(9):1401-9. PubMed ID: 3040923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lung.
    Aroney RS; Bell DR; Chan WK; Dalley DN; Levi JA
    Cancer; 1982 Jun; 49(12):2449-54. PubMed ID: 6280840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer.
    Murray N; Shah A; Osoba D; Page R; Karsai H; Grafton C; Goddard K; Fairey R; Voss N
    J Clin Oncol; 1991 Sep; 9(9):1632-8. PubMed ID: 1651995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy in small cell lung carcinoma. A randomized study of two intensive regimens.
    Lowenbraun S; Birch R; Buchanan R; Krauss S; Durant J; Perez C; Mill W; Vollmer R; Ogden L
    Cancer; 1984 Dec; 54(11):2344-50. PubMed ID: 6093979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
    Havemann K; Wolf M; Holle R; Gropp C; Drings P; Manke HG; Hans K; Schroeder M; Heim M; Victor N
    Cancer; 1987 Mar; 59(6):1072-82. PubMed ID: 3028596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
    J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.